Author:
Gallinat S.,Edling O.,Unger Thomas
Reference317 articles.
1. Abhold RH, Sullivan MJ, Wright JM, Harding JW (1987) Binding, degradation and pressor activity of angiotensin II and III after amino peptidase inhibition with amastatin and bestatin. J Pharmacol Exp Ther 242: 957–962
2. Aceto JF, Baker KM (1990) [Sarl] angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258: H806–H813
3. Admiraal PJJ, Danser AHJ, Sjoukje-Jong M, Pieterman H, Derkx FHM, Schalekamp MADH (1993) Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 21: 173–184
4. Ahmed A, Li XF, Shams M, Gregory J, Rollason T, Barnes NM, Newton JR (1995) Localization of the angiotensin II and its receptor subtype expression in human endometrium and identification of a novel high-affinity angiotensin II binding site. J Clin Invest 96: 848–857
5. Alhenc-Gelas F, Soubrier F, Hubert C, Allegrini J, Corvol P (1989) The peculiar characteristics of the amino acid sequence of angiotensin I converting enzyme, as determined by cDNA cloning of the human endothelial enzyme. J Cardiovasc Pharmacol 14 [suppl 4]: 56–59